Heppner DG - Search Results

1

Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes.

Heppner DG, Gordon DM, Gross M, Wellde B, Leitner W, Krzych U, Schneider I, Wirtz RA, Richards RL, Trofa A, Hall T, Sadoff JC, Boerger P, Alving CR, Sylvester DR, Porter TG, Ballou WR. Heppner DG, et al. J Infect Dis. 1996 Aug;174(2):361-6. doi: 10.1093/infdis/174.2.361. J Infect Dis. 1996. PMID: 8699067

2

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R, Heppner DG, Yuan G, Hollingdale M, Slaoui M, et al. Gordon DM, et al. Among authors: heppner dg. J Infect Dis. 1995 Jun;171(6):1576-85. doi: 10.1093/infdis/171.6.1576. J Infect Dis. 1995. PMID: 7769295 Clinical Trial.

3

Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study.

Ballou WR, Blood J, Chongsuphajaissidhi T, Gordon DM, Heppner DG, Kyle DE, Luxemburger C, Nosten F, Sadoff JC, Singhasivanon P, et al. Ballou WR, et al. Among authors: heppner dg. Parasitology. 1995;110 Suppl:S25-36. doi: 10.1017/s0031182000001463. Parasitology. 1995. PMID: 7784126 Clinical Trial.

4

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum.

Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, Ballou WR, Foulds G, Sadoff JC, Schuster B, et al. Kuschner RA, et al. Among authors: heppner dg. Lancet. 1994 Jun 4;343(8910):1396-7. doi: 10.1016/s0140-6736(94)92526-7. Lancet. 1994. PMID: 7910886 Clinical Trial.

5

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

Gonzalez C, Hone D, Noriega FR, Tacket CO, Davis JR, Losonsky G, Nataro JP, Hoffman S, Malik A, Nardin E, Sztein MB, Heppner DG, Fouts TR, Isibasi A, Levine MM, et al. Gonzalez C, et al. Among authors: heppner dg. J Infect Dis. 1994 Apr;169(4):927-31. doi: 10.1093/infdis/169.4.927. J Infect Dis. 1994. PMID: 8133113 Clinical Trial.

6

Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States.

Gordon DM, Duffy PE, Heppner DG, Lyon JA, Williams JS, Scheumann D, Farley L, Stacey D, Haynes JD, Sadoff JC, Ballou WR. Gordon DM, et al. Among authors: heppner dg. Am J Trop Med Hyg. 1996 Jul;55(1):63-8. doi: 10.4269/ajtmh.1996.55.63. Am J Trop Med Hyg. 1996. PMID: 8702024 Clinical Trial.

7

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.

Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG. Nosten F, et al. Among authors: heppner dg. Lancet. 1996 Sep 14;348(9029):701-7. doi: 10.1016/s0140-6736(96)04465-0. Lancet. 1996. PMID: 8806288 Clinical Trial.

8

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M. Stoute JA, et al. Among authors: heppner dg. N Engl J Med. 1997 Jan 9;336(2):86-91. doi: 10.1056/NEJM199701093360202. N Engl J Med. 1997. PMID: 8988885 Free article. Clinical Trial.

9

Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia.

Nosten F, Luxemburger C, Kyle DE, Gordon DM, Ballou WR, Sadoff JC, Brockman A, Permpanich B, Chongsuphajaisiddhi T, Heppner DG. Nosten F, et al. Among authors: heppner dg. Am J Trop Med Hyg. 1997 May;56(5):526-32. doi: 10.4269/ajtmh.1997.56.526. Am J Trop Med Hyg. 1997. PMID: 9180603 Clinical Trial.

10

Activation of gammadelta T cells in malaria: interaction of cytokines and a schizont-associated Plasmodium falciparum antigen.

Pichyangkul S, Saengkrai P, Yongvanitchit K, Stewart A, Heppner DG. Pichyangkul S, et al. Among authors: heppner dg. J Infect Dis. 1997 Jul;176(1):233-41. doi: 10.1086/514029. J Infect Dis. 1997. PMID: 9207372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters